Sling Therapeutics (Series C)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
September 27, 2026
Vertical
Pharmaceuticals and Biotech
Funding URL
View Funding Page
Funding Amount
$123,000,000
Company Info
Market
Clinical-stage biopharmaceuticals
Location
Ann Arbor, Michigan, USA
Coinvestors
TPG Life Sciences Innovations, Sectoral Asset Management
Company Description

Sling Therapeutics is a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED).

Links
Back to HomeBack to Pharmaceuticals and Biotech DealsView Funding Announcement